 Home > Active Ingredient News > Digestive System Information > AP&T: Risk of schizophrenia and new-onset inflammatory bowel disease

AP&T: Risk of schizophrenia and new-onset inflammatory bowel disease

 Last Update: 2022-05-10
 Source: Internet
 Author: User

Tags

global public health

ci systems

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Risk of schizophrenia and new-onset inflammatory bowel disease Schizophrenia is a common serious mental illness, and its patients account for about 50% of the total number of hospitalized mental patients in China, and the global lifetime prevalence rate is about 0.

diagnosis

Among 116,164 patients with schizophrenia and 464,656 matched controls, patients had a significantly higher overall incidence of IBD (1.

Thus, this population-based cohort study demonstrated a significant association between schizophrenia and subsequent development of IBD

Original source:

Kuan-Yi Sung.

Kuan-Yi Sung.
Et al.
Schizophrenia and risk of new-onset inflammatory bowel disease: a nationwide longitudinal study .
Alimentary Pharmacology & Therapeutics.
2022.
Schizophrenia and risk of new-onset inflammatory bowel disease: a nationwide longitudinal study Leave a

message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Vonoprazan

CAS No.: 1260141-27-2

Pharmacy Grade

$3483/KG FOB

Magnesium oxide

CAS No.: 1309-48-4

Industrial Grade

$491-498/MT FOB

Famotidine (Gastrointestinal)

CAS No.: 76824-35-6

Pharmacy Grade

$1/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.